Rosa Pharmaceuticals, Inc. Announces Completion of its Planned Corporate Change to Rosa & Co LLC
“As one of the world’s modeling-and-simulation leaders focused on the pharmaceutical industry, the company’s transformation into Rosa & Co reflects our renewed emphasis on providing exceptional consulting services.” said Sam Holtzman, PhD, Chairman, President, and CEO of Rosa & Co.
About Rosa & Co.